How do you approach patients with stage III unresectable, combined histology NSCLC/SCLC?

Topics: Thoracic Malignancies • Medical Oncology

Following chemoradiation, would you consider maintenance durvaluamb as for NSCLC even given the SCLC component?

Answer from: Medical Oncologist at Academic Institution

This is a difficult question and I am not sure there is a "right answer". I would probably discuss with my pathologist what seems to be the more dominant histology if there is one. I would choose cisplatin with etoposide rather than carboplatin with paclitaxel as the chemotherapy backbone due to the...

Comments

Medical Oncologist at University of Pittsburgh
I agree. A concurrent chemoradiotherapy backbone w...

Related Questions